|
PPCS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99960048519188E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58970003827363E-09 |
| Normal-vs-Stage2 |
7.296100E-03 |
| Normal-vs-Stage3 |
3.80290000000505E-05 |
| Normal-vs-Stage4 |
2.099600E-02 |
| Stage1-vs-Stage2 |
8.986800E-01 |
| Stage1-vs-Stage3 |
4.362800E-01 |
| Stage1-vs-Stage4 |
8.672400E-01 |
| Stage2-vs-Stage3 |
7.059000E-01 |
| Stage2-vs-Stage4 |
8.565000E-01 |
| Stage3-vs-Stage4 |
5.695800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21879975398554E-10 |
| Normal-vs-AfricanAmerican |
7.37709999976133E-07 |
| Normal-vs-Asian |
5.505800E-02 |
| Caucasian-vs-AfricanAmerican |
7.256600E-01 |
| Caucasian-vs-Asian |
4.683600E-01 |
| AfricanAmerican-vs-Asian |
4.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.98190019951028E-10 |
| Normal-vs-Female |
3.55860000356145E-08 |
| Male-vs-Female |
6.784200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.1249000000001E-05 |
| Normal-vs-Extreme_Weight |
1.92919999975061E-08 |
| Normal-vs-Obese |
1.39500000440052E-08 |
| Normal-vs-Extreme_Obese |
3.755700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.988800E-01 |
| Normal_Weight-vs-Obese |
6.093600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.474600E-01 |
| Extreme_Weight-vs-Obese |
4.249600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.762200E-01 |
| Obese-vs-Extreme_Obese |
8.168400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.355000E-04 |
| Normal-vs-Age(41-60Yrs) |
8.53839998704586E-09 |
| Normal-vs-Age(61-80Yrs) |
6.05119954144584E-10 |
| Normal-vs-Age(81-100Yrs) |
1.353500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.972400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.301400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.618800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.125800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.556200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.719800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.65339980490376E-10 |
| Normal-VS-Type2 PRCC |
5.67499999999388E-05 |
| Normal-VS-KIRP CIMP |
7.64440000189381E-08 |
| Normal-VS-Unclassified PRCC |
4.72309999999254E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.601400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.062970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.203200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.120300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.926800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.947840E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.40110000005301E-07 |
| Normal-vs-N1 |
1.481590E-03 |
| Normal-vs-N2 |
7.459700E-02 |
| N0-vs-N1 |
3.932800E-01 |
| N0-vs-N2 |
4.480800E-01 |
| N1-vs-N2 |
2.046800E-01 |
|
|
